| scholarly article | Q13442814 |
| P2093 | author name string | Pincus T | |
| Callahan LF | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| comorbidity | Q1414874 | ||
| socioeconomics | Q1643441 | ||
| P304 | page(s) | 841-845 | |
| P577 | publication date | 1986-10-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity | |
| P478 | volume | 13 |
| Q36535457 | A Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in Women |
| Q40626172 | A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis |
| Q77627758 | Anti-CD4 monoclonal antibodies in rheumatoid arthritis |
| Q33579212 | Antibody deficiency associated with gold treatment: natural history and management in 22 patients |
| Q35025293 | Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry |
| Q36596894 | Atherogenic lipid profiles and its management in patients with rheumatoid arthritis |
| Q37087438 | Biologic treatments for systemic rheumatic diseases |
| Q42560566 | Capturing real-life patient care in psoriatic arthritis and its risks: the challenge of analysing registry data |
| Q34385631 | Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care |
| Q82736530 | Combined use of propagation velocity and intraventricular dispersion of E wave velocity for the evaluation of diastolic functions in patients with rheumatoid arthritis |
| Q44377651 | Cortisone therapy today |
| Q33910506 | Cross-cultural validation of the Educational Needs Assessment Tool in RA in 7 European countries |
| Q81346281 | Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease |
| Q35605663 | Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study |
| Q40839495 | Disease-modifying antirheumatic drugs. Using their clinical pharmacological effects as a guide to their selection |
| Q47815824 | Does practice mirror the evidence base in the treatment of rheumatoid arthritis? |
| Q37292191 | Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors |
| Q35933703 | Durability and rapidity of response to anakinra in patients with rheumatoid arthritis |
| Q35029916 | Dyslipidaemia in rheumatological autoimmune diseases |
| Q33566590 | Dyslipoproteinaemia in a subset of patients with rheumatoid arthritis |
| Q80495670 | Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up |
| Q33571816 | Economic and quality-of-life impact of NSAIDs in rheumatoid arthritis: A conceptual framework and selected literature review |
| Q34896078 | Epstein-Barr virus and rheumatoid arthritis: is there a link? |
| Q24674079 | Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years |
| Q34286316 | Formal education and back pain: a review |
| Q40039972 | Hormonal contraception and the development of autoimmunity: A review of the literature |
| Q42081434 | Identification of dysregulated genes in rheumatoid arthritis based on bioinformatics analysis |
| Q35059538 | Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease? |
| Q79339706 | Improving survival in inflammatory rheumatic diseases: a neglected goal? |
| Q35086458 | Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis |
| Q33959133 | Infliximab: a review of its use in the management of rheumatoid arthritis |
| Q34104339 | Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis |
| Q35352791 | Intestinal permeability and inflammation in patients on NSAIDs |
| Q35848427 | Methotrexate increases expression of cell cycle checkpoint genes via JNK activation |
| Q35549071 | No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset |
| Q81739887 | Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis |
| Q36647506 | Pathogenesis of rheumatoid arthritis: its relevance to therapy in the '90s |
| Q41915915 | Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine |
| Q35620858 | Predictors of diastolic dysfunction in rheumatoid arthritis |
| Q34150320 | Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation |
| Q53537712 | Right ventricular diastolic abnormalities in rheumatoid arthritis and its relationship with left ventricular and pulmonary involvement. A tissue Doppler echocardiographic study. |
| Q34076916 | Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT study |
| Q36326701 | Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis |
| Q35548697 | Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis |
| Q33578306 | Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients |
| Q38856510 | Synovial fluid proteome in rheumatoid arthritis |
| Q41038057 | The underestimated long term medical and economic consequences of rheumatoid arthritis. |
| Q36165321 | Unmet needs in rheumatoid arthritis |
| Q81881480 | Use of tissue Doppler and its comparison with other conventional Doppler techniques in the assessment of diastolic functions in patients with active rheumatoid arthritis |
| Q35630128 | Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis |
| Q80314055 | [Rheumatoid arthritis and cardiovascular complications] |
| Q74247530 | [Risk of ulcer and its prophylaxis in therapy with non-steroidal antirheumatic drugs] |
Search more.